WilliamSikovMD
Oncology • Providence, RIBreast Cancer
Breast Medical Oncology, Professor of Medicine, Obstetrics and Gynecology, Warren Alpert Medical School of Brown University
Dr. Sikov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Breast Health Center
101 Dudley St.
Providence, RI 02905Phone+1 401-453-7540Fax+1 401-453-7785
Summary
- William Sikov, MD, is a breast medical oncology specialist based in Providence, RI. He has subspecialties in advanced and early-stage breast cancer and clinical trials. Dr. Sikov completed his medical education at Yale School of Medicine in 1982, followed by a residency at UPMC Medical Education from 1982 to 1985. He further pursued his specialty by completing a fellowship in Hematology and Medical Oncology at Tufts Medical Center from 1986 to 1989.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1986 - 1989
UPMC Medical EducationResidency, 1982 - 1985
Yale School of MedicineClass of 1982
Certifications & Licensure
RI State Medical License 1989 - 2026
MA State Medical License 1986 - 2025
PA State Medical License 1983 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.Karen L Smith, Fengmin Zhao, Ingrid A Mayer, Amye J Tevaarwerk, Sofia F Garcia
Cancer. 2024-05-15 - 16 citationsAKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.Maysa M Abu-Khalaf, K Alex Hodge, Christos Hatzis, Elisa Baldelli, Emna El Gazzah
NPJ Precision Oncology. 2023-02-16 - 15 citationsLuminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response.Kevin J Thompson, Roberto A Leon-Ferre, Jason P Sinnwell, David M Zahrieh, Vera J Suman
NAR Cancer. 2022-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
